Atlas Trials

Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients

Clinical trial NCT01491295 · UNKNOWN

Trial details

NCT number
NCT01491295
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2012-09-01
Primary completion
2019-12-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.